Needham: Reiterates Cartesian Therapeutics (RNAC.US) rating and adjusted from buy to buy rating, target price is $42.00.
Needham：重申Cartesian Therapeutics(RNAC.US)评级，由买入调整至买入评级, 目标价42.00美元。
Needham: Reiterates Cartesian Therapeutics (RNAC.US) rating and adjusted from buy to buy rating, target price is $42.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.